Exelixis | Capital Ordinário



Ordinary Share Capital Alterar Data
Acadia Pharmaceuticals USD 167.36M 167.35M 2025-06
Agios Pharmaceuticals USD 58.04M 57.96M 2025-06
Amgen USD 538M 33.04B 2025-06
AstraZeneca USD 1.55B 1.16B 2025-06
Bayer EUR 982.42M 1.53B 2025-06
BioMarin Pharmaceutical USD 192M 191.81M 2025-06
Bristol-Myers Squibb USD 2.04B 1.74B 2025-06
Cytokinetics USD 119.6M 119.48M 2025-06
Eisai JPY 282.12M 44.7B 2025-06
Eli Lilly USD 946.83M 354.23M 2025-06
Exelixis USD 270.13M 269.86M 2025-07
Genmab DKK 10M 56M 2025-03
Glaxosmithkline GBP 1.35B 0 2024-12
Incyte USD 194.12M 193.93M 2025-06
Ionis Pharmaceuticals USD 159.2M 159.04M 2025-06
MacroGenics USD 628K 1000 2024-12
Merck USD 1.79B 0 2025-03
Moderna USD 389M 388.96M 2025-06
Neurocrine Biosciences USD 99M 0 2025-06
Novartis USD 793M 0 2024-12
Pfizer USD 5.68B 5.2B 2025-06
Sanofi 1.25B 52.53M 2025-03
Takeda JPY 1.56B 1.69T 2025-06
Ultragenyx Pharmaceutical USD 96.35M 2.45M 2025-06
Xencor USD 71.3M 70.58M 2025-06


Exelixis Capital Ordinário - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Aug 2025.